Combination of antiangiogenic RAD001 and ionizing radiation in therapy of malignant tumors

被引：0
|
作者：
Manegold, Philipp [1 ]
Paringer, Carmen [1 ]
Kulka, Ulrike [1 ]
Wilkowski, Ralf [1 ]
Jauch, Karl-Walter [1 ]
Guba, Markus [1 ]
Bruns, Christiane J. [1 ]
机构：
[1] Univ Munich Grosshadern, Munich, Germany
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4397
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Therapeutic effect of everolimus (RAD001) in combination with antiangiogenic chemotherapy for gastric cancer in vivo
    Cejka, D.
    Preusser, M.
    Sieghart, W.
    Strommer, S.
    Werzowa, J.
    Fuereder, T.
    Wacheck, V.
    EJC SUPPLEMENTS, 2006, 4 (12): : 25 - 25
  • [2] Oncolytic Transcriptionally Retargeted Adenovirus Expressing Nitroreductase in Combination with Antiangiogenic Drug RAD001
    Lukashev, Alexander N.
    Homicsko, Krizstian G.
    Fuerer, Cristophe
    Iggo, Richard
    MOLECULAR THERAPY, 2006, 13 : S246 - S246
  • [3] Inhibition of HIF-1α by RAD001 (everolimus) in combination with antiangiogenic chemotherapy in a gastric cancer model
    Cejka, D.
    Preusser, M.
    Sieghart, W.
    Strommer, S.
    Werzowa, J.
    Fuereder, T.
    Wacheck, V.
    PHARMACOLOGY, 2006, 78 (03) : 153 - 153
  • [4] Effectiveness of RAD001 (everolimus) in combination with endocrine therapy varies with cell phenotype
    Farmer, I
    Poncholi, S.
    Thornhill, A.
    Evans, D. B.
    Lane, H. A.
    Dowsett, M.
    Martin, L-A
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S81 - S81
  • [5] A phase I trial of RAD001 in combination with cetuximab in patients with advanced solid tumors
    Avadhani, A. N.
    Flaherty, K.
    Rosen, M.
    Veronese, M. L.
    Harlacker, K.
    Johnson, S. W.
    Sherman, E.
    Griggs, W.
    Divgi, C. R.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer
    Manegold, Philipp C.
    Paringer, Carmen
    Kulka, Ulrike
    Krimmel, Klaus
    Eichhorn, Martin E.
    Wilkowski, Ralf
    Jauch, Karl-Walter
    Guba, Markus
    Bruns, Christiane J.
    CLINICAL CANCER RESEARCH, 2008, 14 (03) : 892 - 900
  • [7] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Jennifer A. Chan
    Robert J. Mayer
    Nadine Jackson
    Paige Malinowski
    Eileen Regan
    Matthew H. Kulke
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1241 - 1246
  • [8] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Chan, Jennifer A.
    Mayer, Robert J.
    Jackson, Nadine
    Malinowski, Paige
    Regan, Eileen
    Kulke, Matthew H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1241 - 1246
  • [9] Advanced Neuroendocrine Tumors: Authorization for RAD001 with EMA requested
    Roth, Irene
    VISZERALMEDIZIN, 2011, 27 (03): : 256 - 256
  • [10] Phase III Data in neuroendocrine Tumors show: RAD001 as Monotherapy and in Combination with Sandostatin© LAR© effectively
    Roth, Irene
    VISZERALMEDIZIN, 2010, 26 (04): : 290 - 290
12345